Zybio becomes a member of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Recently, Zybio has officially become a member of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), marking a new chapter for Zybio in the field of global laboratory testing. Zybio looks forward to strengthening communication with excellent colleagues from all over the world, and jointly utilizing the expertise and innovative technologies to improve the quality of laboratory testing and patient healthcare.
On May 15, Dirui announced that its in vitro diagnostic products for chemiluminescence immunoassay, clinical chemistry, coagulation and urinalysis have recently received the IVDR issued by the EU's notified body, TÜV SÜD.
The IVDR certification of the above products with independent intellectual property rights signifies that Dirui, not only helps the China¡¯s IVD market to realize domestic substitution, but also expands the influence and competitiveness of China's smart manufacturing in the international market, which will have a positive impact on the promotion of domestic brands in the international business.
Siemens Healthineers and Xi'an Daxing Hospital sign an eight-year strategic partnership agreement
On May 7, Daxing Hospital and its planned new medical institutions will work together with Siemens Healthineers to carry out the in-depth cooperation in a variety of fields and dimensions such as the construction of an innovation ecosystem, talent cultivation and international exchanges, scientific research and consulting and discipline construction, the enhancement of the capacity of the 5G Diagnostic and Treatment Center, and the clinical transformation of scientific research achievements in the coming eight years, with the aim of further enhancing the overall level of healthcare services at Daxing Hospital The aim is to further improve the overall medical service level of Daxing Hospital and provide local patients with more high-quality, efficient and convenient medical services.
Biotree and SCIEX collaborate to establish a multi-organomics laboratory, pioneering a new era of clinical translation of mass spectrometry
On May 10, Biotree and SCIEX signed a strategic cooperation agreement and inaugurated the multi-organomics and clinical translational mass spectrometry technology innovation center, which was established by both parties.
The successful signing of this strategic cooperation agreement and the unveiling ceremony marks a brand new stage of cooperation between Biotree and SCIEX in the field of scientific research services. Both parties will continue to work hand in hand to further strengthen in-depth cooperation in biomedical services and medical translational services, and jointly promote the rapid development of clinical translational research.
On May 11, Human Diagnostics signed a cooperation agreement with Huaixi Medical. The two sides will develop the market in the related product areas to realize a new chapter of win-win development.
